The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Sep 06, 2026
Snapshot (as of Sep 06, 2026): McKesson Corporation (MCK) pays a $3.40 annual dividend ($0.94 quarterly), yielding 0.37% at $907.99/share. Next ex-dividend date 2026-09-01. 26 consecutive years of dividend growth (Dividend Aristocrat). Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 0.37%
Annual Dividend: $3.40 per share
Payout Ratio: 8.6%
Ex-Dividend Date: 2026-09-01
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 33
McKesson Corporation dividend income comes from one of the largest healthcare distribution businesses in the world, spanning U.S. pharmaceutical distribution, medical-surgical supply, and its Prescription Technology Solutions segment. MCK currently yields 0.37%, with a trailing annual dividend rate of $3.40 per share paid quarterly, and the next ex-dividend date falls on September 1, 2026. A Dividend Aristocrat with 26 consecutive years of increases, MCK is built for investors who prioritize dividend growth over current income. With a beta of 0.307, the stock moves far less than the broader market, which suits investors who want growth without sharp price swings.
McKesson Corporation pays out 8.6% of earnings as dividends, a payout ratio classified as conservative (below 40%). That figure is exceptionally low, meaning the company retains the vast majority of earnings, and the business description points to recurring demand across pharmaceutical distribution, medical-surgical supply, and specialty oncology services as the operational foundation supporting McKesson Corporation dividend safety. The most significant data-supported pressure point is that a payout ratio this low leaves little room to argue the dividend is stretched, but it also means yield expansion depends almost entirely on earnings growth rather than payout expansion.
McKesson Corporation dividend history shows a CAGR of 10.3% per year from 2011 to 2025. Per-share payments grew from $0.78 to $3.06 over that window (2026 is a partial year and excluded from the rate calculation). The smallest annual increase in the window was 2.6% in 2012, while the largest reached 17.7% in 2018, showing the range of outcomes investors have seen across different years.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +14.8% | $2.02 (2022) | $3.06 (2025) |
| 5-Year | +13.0% | $1.66 (2020) | $3.06 (2025) |
| 10-Year | +11.4% | $1.04 (2015) | $3.06 (2025) |
MCK fits growth-and-income investors who want dividend expansion from a large healthcare distribution business and are willing to accept a low current yield in exchange for it. At 0.37%, the yield is low (below 2%) and sits above the 5-year average of 0.26%, but neither figure is meaningful for investors who need current income. What MCK delivers instead is a 26-year consecutive increase streak, Dividend Aristocrat status, and a 10.3% annual growth rate over the past 14 years. The trade-off is straightforward: investors get a fast-growing dividend backed by an 8.6% payout ratio, but the starting yield is too thin to generate meaningful income in the near term.
MCK is a Dividend Aristocrat with 26 consecutive years of dividend increases.
| Payment Date | Amount per Share |
|---|---|
| 2026-09-01 | $0.9400 |
| 2026-06-01 | $0.8200 |
| 2026-03-02 | $0.8200 |
| 2025-12-01 | $0.8200 |
| 2025-09-02 | $0.8200 |
| 2025-06-02 | $0.7100 |
| 2025-03-03 | $0.7100 |
| 2024-12-02 | $0.7100 |
| 2024-08-30 | $0.7100 |
| 2024-06-03 | $0.6200 |
| Year | Total Dividends |
|---|---|
| 2026 | $2.5800 |
| 2025 | $3.0600 |
| 2024 | $2.6600 |
| 2023 | $2.3200 |
| 2022 | $2.0200 |
Project income from MCK with the MCK dividend calculator or track your full portfolio with the dividend tracker.